ANNUAL REPORT
FISCAL YEAR 2058 — A RECORD YEAR OF GROWTH, INNOVATION, AND SHAREHOLDER VALUE CREATION.
LETTER TO SHAREHOLDERS
DEAR SHAREHOLDERS,
FISCAL YEAR 2058 WAS A TRANSFORMATIVE YEAR FOR WEYLAND-YUTANI CORPORATION. WE DELIVERED RECORD REVENUE OF $45.2 TRILLION, AN 8.3% INCREASE OVER THE PRIOR YEAR, WHILE EXPANDING NET INCOME MARGINS TO 26.8%. THESE RESULTS REFLECT THE STRENGTH OF OUR DIVERSIFIED BUSINESS MODEL AND THE EXCEPTIONAL EXECUTION OF OUR TEAMS ACROSS ALL SEVEN OPERATING DIVISIONS.
OUR TERRAFORMING OPERATIONS DIVISION ACHIEVED A SIGNIFICANT MILESTONE, SURPASSING $8 TRILLION IN ANNUAL REVENUE FOR THE FIRST TIME AS WE BROUGHT 47 NEW ATMOSPHERIC PROCESSING INSTALLATIONS ONLINE. THE CYBERNETICS DIVISION LAUNCHED THE DAVID-9 SERIES, OUR MOST ADVANCED SYNTHETIC PLATFORM TO DATE, TO STRONG COMMERCIAL AND INSTITUTIONAL DEMAND.
IN ENERGY SYSTEMS, OUR NEXT-GENERATION FUSION REACTOR ACHIEVED COMMERCIAL VIABILITY, OPENING A NEW REVENUE STREAM ESTIMATED AT $3 TRILLION ANNUALLY AT FULL DEPLOYMENT. HEALTH SCIENCES CONTINUED ITS RAPID GROWTH WITH THE MEDPOD 5000 RECEIVING REGULATORY APPROVAL IN 42 JURISDICTIONS, BRINGING OUR AUTONOMOUS SURGICAL TECHNOLOGY TO BILLIONS MORE PATIENTS.
WE ALSO MADE STRATEGIC INVESTMENTS IN OUR FUTURE, ALLOCATING $6.8 TRILLION TO RESEARCH AND DEVELOPMENT, REPRESENTING 15% OF REVENUE. THIS INVESTMENT SUPPORTS OVER 200 ACTIVE R&D PROGRAMS SPANNING FTL PROPULSION OPTIMIZATION, ADVANCED MATERIALS, SYNTHETIC COGNITION, AND NEXT-GENERATION ATMOSPHERIC PROCESSING TECHNOLOGY.
OUR COMMITMENT TO RESPONSIBLE OPERATIONS REMAINED STEADFAST. WE INVESTED $1.2 TRILLION IN SUSTAINABILITY INITIATIVES, EXPANDED THE EXPLORERS ACADEMY TO 250,000 STUDENTS, AND MAINTAINED OUR POSITION AS THE LEADING EMPLOYER OF MILITARY VETERANS WORLDWIDE.
LOOKING AHEAD, I AM CONFIDENT IN OUR STRATEGIC POSITION. THE DEMAND FOR TERRAFORMING, ENERGY, AND HEALTHCARE SERVICES CONTINUES TO ACCELERATE AS HUMANITY EXPANDS ACROSS THE STARS. WEYLAND-YUTANI IS UNIQUELY POSITIONED TO MEET THAT DEMAND.
ON BEHALF OF THE BOARD OF DIRECTORS AND OUR 527,000 EMPLOYEES, THANK YOU FOR YOUR CONTINUED TRUST AND INVESTMENT IN OUR COMPANY.
KEY METRICS
DIVISION PERFORMANCE
TERRAFORMING OPERATIONS
47 NEW ATP INSTALLATIONS. 12 ATMOSPHERES DECLARED BREATHABLE. RECORD BACKLOG OF $24T IN CONTRACTED PROJECTS.
CYBERNETICS & SYNTHETICS
DAVID-9 SERIES LAUNCH. 15,000 UNITS DELIVERED. AUTONOMOUS SYSTEMS DIVISION GREW 22% ON INDUSTRIAL DEMAND.
ENERGY SYSTEMS
NEXT-GEN FUSION REACTOR COMMERCIALIZED. FTL DRIVE EFFICIENCY IMPROVED 12%. 30 NEW POWER INSTALLATIONS COMPLETED.
SECURITY SOLUTIONS
EXPANDED GOVERNMENT CONTRACTS. NEW PERIMETER DEFENSE SYSTEMS FOR 85 COLONIES. CYBERSECURITY DIVISION GREW 18%.
HEALTH SCIENCES
MEDPOD 5000 APPROVED IN 42 JURISDICTIONS. PHARMACEUTICAL DIVISION SECURED 12 NEW PATENTS. COLONY HEALTHCARE CONTRACTS EXPANDED.
ELECTRONICS & BIOLOGICAL SCIENCES
HOLOGRAPHIC SYSTEMS ADOPTED BY 200+ COMMERCIAL CLIENTS. BIOLOGICAL RESEARCH DELIVERED 8 NEW COMMERCIAL APPLICATIONS.
STRATEGIC PRIORITIES
1. ACCELERATE TERRAFORMING CAPACITY
INCREASE ATMOSPHERIC PROCESSOR PRODUCTION BY 30% OVER THE NEXT THREE YEARS TO MEET SURGING DEMAND FROM THE COLONIAL ADMINISTRATION AND PRIVATE COLONIZATION ENTITIES. INVEST $4T IN NEW MANUFACTURING FACILITIES ON EARTH AND LUNA.
2. EXPAND HEALTH SCIENCES GLOBALLY
DEPLOY MEDPOD TECHNOLOGY TO ALL COLONY WORLDS AND EXPAND EARTH-SIDE DISTRIBUTION TO UNDERSERVED MARKETS. TARGET: 500,000 MEDPOD INSTALLATIONS BY FY2062, MAKING AUTONOMOUS SURGICAL CARE UNIVERSALLY ACCESSIBLE.
3. ADVANCE SYNTHETIC INTELLIGENCE
CONTINUE INVESTMENT IN THE DAVID SERIES PLATFORM WITH A FOCUS ON COGNITIVE ENHANCEMENT AND SPECIALIZED APPLICATIONS. EXPAND THE SYNTHETIC WORKFORCE TO SUPPORT HAZARDOUS OPERATIONS AND ACCELERATE COLONY DEVELOPMENT.
4. DISCIPLINED CAPITAL RETURN
MAINTAIN OUR COMMITMENT TO RETURNING CAPITAL TO SHAREHOLDERS THROUGH DIVIDENDS AND SHARE REPURCHASES. THE BOARD HAS AUTHORIZED A NEW $2T BUYBACK PROGRAM AND APPROVED A 10% INCREASE IN THE QUARTERLY DIVIDEND.
RISK FACTORS
INVESTORS SHOULD CAREFULLY CONSIDER THE FOLLOWING RISK FACTORS, AMONG OTHERS, WHEN EVALUATING AN INVESTMENT IN WEYLAND-YUTANI CORPORATION SECURITIES:
THIS IS NOT AN EXHAUSTIVE LIST OF RISK FACTORS. PLEASE REFER TO OUR ANNUAL REPORT ON FORM 10-K FILED WITH THE SECURITIES AND EXCHANGE COMMISSION FOR A COMPLETE DISCUSSION OF RISKS AND UNCERTAINTIES.